Healthy high growth potential

Results

1526

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1526 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AXSM
US$218.201.6%86.5%US$11.3bUS$285.4214.761.1%n/aPharmaceuticals & Biotech
GOLDR
NOK 7.883.4%n/aNOK 451.7mn/a20.786.0%n/aMaterials
TMGH
ج.م97.00-1.4%76.2%ج.م199.9bج.م141.9012.935.9%0.3%Real Estate Management and Development
WAYS
SEK 39.201.8%-1.3%SEK 343.8mSEK 58.00208.678.5%0%Tech
LPK
€13.70-16.7%68.9%€335.0m€22.753.4116.6%0%Tech
TGTX
US$51.694.4%82.6%US$7.1bUS$69.7116.621.3%n/aPharmaceuticals & Biotech
MOD
US$195.14-2.2%44.6%US$10.7bUS$310.2971.951.3%n/aCapital Goods
SAUD3
R$13.921.5%7.6%R$40.7bR$17.6938.631.9%5.8%Healthcare
RHM
€1,178.800.9%-24.3%€55.0b€1,679.3845.530.5%1.0%Capital Goods
LITE
US$827.60-11.2%614.1%US$78.3bUS$1,148.3024.6104.4%n/aTech
CRDO
US$234.82-12.4%121.5%US$45.9bUS$283.2392.727.7%n/aSemiconductors
NVDA
US$217.56-2.9%24.0%US$5.3tUS$302.8333.022.9%0.5%Semiconductors
SPCX
US$139.65-4.4%n/aUS$1.9tUS$213.5079.956.5%n/aTelecom
9218
JP¥768.001.6%-9.8%JP¥8.0bn/a33.928.9%1.3%Healthcare
3036
NT$205.00-4.7%68.0%NT$256.0bNT$314.8610.728.9%3.8%Tech
4417
JP¥4,600.000.9%43.3%JP¥65.7bJP¥5,800.0043.026.4%1.1%Software
456A
JP¥1,359.00-4.0%n/aJP¥124.5bn/a38.423.4%n/aRetail
6787
JP¥17,480.00-7.0%96.8%JP¥442.2bJP¥28,400.0022.830.1%0.9%Tech
5038
JP¥2,227.005.3%-22.7%JP¥31.6bJP¥2,270.0028.020.3%0.9%Healthcare
MDGL
US$540.160.7%37.9%US$12.1bUS$678.069.763.7%n/aPharmaceuticals & Biotech
AAZ
UK£3.93-4.8%138.6%UK£448.8mUK£5.6834.525.9%0.7%Materials
CDR
zł256.50-3.7%1.8%zł25.6bzł236.0549.639.6%0.4%Media
AGP
€7.17-0.1%-10.6%€130.7m€8.5726.339.1%n/aCapital Goods
FWRY
ج.م19.000.6%39.1%ج.م64.7bج.م22.4524.327.3%n/aDiversified Financials
Page 1 of 43